Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J
Right arrow Articles by Tian, Z
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J
Right arrow Articles by Tian, Z
Haematologica, Vol 89, Issue 3, 338-347
Copyright © 2004 by Ferrata Storti Foundation


Journal Article

Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy

J Zhang, R Sun, H Wei, J Zhang, and Z Tian

School of Life Sciences, University of Science and Technology of China, Hefei City, Anhui, China.

BACKGROUND AND OBJECTIVES: Natural killer (NK)-92 cells are effective against a broad range of malignant targets both in vitro and in vivo. Interleukin-15 (IL-15) is an important cytokine for NK cell development and differentiation. IL-15 gene-modified NK-92 cells need to be characterized and their clinical implications investigated. DESIGN AND METHODS: IL-15 cDNA was inserted into a pcDNA3 eukaryotic expression vector and the recombinant vector (pcDNA3-IL15) was tranfected into NK-92 cells. The IL-15 gene-modified NK-92 cells (NK92-IL15) were cloned and characterized with regard to their cytokine production, proliferation, cytotoxicity and surface phenotype. RESULTS: NK92-IL15 cells continuously produced a high level of IL-15 in culture supernatant, which made the cells proliferate significantly more rapidly in response to stimulation with low doses of IL-2 or IL-15; the cumulative number of cells in long-term culture was also significantly higher. NK92-IL15 cells became adherent to plastic and their expression of CD54 increased, which may explain their improved proliferating potential, like adherent NK cells. NK92-IL15 cells were more strongly cytotox against a broad range of target tumor cells than the parent NK-92 cells, and this increased cytotoxicity was correlated to the increased expression of cytotoxic effector molecules, such as perforin, Fas ligand and IFNgamma, and up- or down-regulated expression of activating or inhibitory NK cell receptors (NKG2D or NKG2A/CD94). INTERPRETATION AND CONCLUSIONS: These results demonstrate that NK92-IL15 cells are promising for adoptive cellular immunotherapy.


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. R. Ostberg, B. E. Dayanc, M. Yuan, E. Oflazoglu, and E. A. Repasky
Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells
J. Leukoc. Biol., November 1, 2007; 82(5): 1322 - 1331.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
A. Sun, H. Wei, R. Sun, W. Xiao, Y. Yang, and Z. Tian
Human Interleukin-15 Improves Engraftment of Human T Cells in NOD-SCID Mice
Clin. Vaccine Immunol., February 1, 2006; 13(2): 227 - 234.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Imai, S. Iwamoto, and D. Campana
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
Blood, July 1, 2005; 106(1): 376 - 383.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. J. Sussman, R. Parihar, K. Winstead, and F. D. Finkelman
Prolonged Culture of Vaccine-Primed Lymphocytes Results in Decreased Antitumor Killing and Change in Cytokine Secretion
Cancer Res., December 15, 2004; 64(24): 9124 - 9130.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2004 by the Ferrata Storti Foundation.